At mid-range doses like 75 units, most patients experience manageable nausea, reduced appetite, and occasional digestive changes that typically improve within one to two weeks
2013;11(1):1720 Schmieder RE, Bakris G, Weir MR
Still monitor iron/ ferritin
Patients should seek medical advice if they experience symptoms of thyroid dysfunction despite treatment, or if they develop concerning symptoms such as difficulty swallowing, voice changes, or a rapidly enlarging neck mass
The work described in this publication benefited from the support of the Metabolomics Shared Resource and of the Biobank Shared Resources (BSR) at the Wilmot Cancer Institute, supported in part by a University of Rochester Wilmot Cancer Institute Support Grant (P30CA272302)